Inguinal hernia is one of the most frequently found surgical problems, accounting for about 70-75 per cent of all hernia operations. Inguinal hernia represents a social disease, with considerable management costs. All classifications of inguinal hernia have something of arbitrary and artificial, and unfortunately are based on anatomic and functional criteria. Moreover, single hernia defect can be classified only during the operation and not in a preoperative setting. The aim of this study has been to evaluate the operative times and consequently identify factors that affect the surgical time. In this way we hope to create a new classification useful to standardize the operative time management. From consecutive patients were enrolled which underwent to inguinal hernioplasty, and they have been observed by the same surgical team. We evaluated clinical parameters (age, sex, BMI, hernia size defect, reducibility, primitive or recurrent hernia, previous hernia surgery) and compared them with surgical times. Data analysis shows a statistically significant relationship between reducibility, recurrent hernia, male gender, BMI and surgical times. This study confirms that an optimal clinical patient evaluation should always be the first step to an effective organizational choice and it allows realistic predictions about the duration of inguinal hernioplasty.
This study demonstrated the feasibility of CE-IOUS during whole LT. However, we failed to demonstrate any advantages of CE-IOUS over IOUS. Therefore, IOUS currently remains the gold-standard imaging technique for the intraoperative assessment of vascular patency.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.